To determine if the novel epigenomic alterations identified in Mtm1 KO mice are relevant to human XLMTM, we applied to XLMTM patient samples an established analytical pipeline for characterizing DNA methylation changes in rare genetic disorders of epigenetic regulation [16, 19, 51]. The gene discussed is MTM1; the disease is X-linked myotubular myopathy.